Skip to main content

Table 1 Clinical characteristics of the study subjects according to the criteria of ATPIII

From: Effect of HDL composition and particle size on the resistance of HDL to the oxidation

  Low-HDL-C Control P
N (Men/Women) 36 (25/11) 41 (19/22) 0.027
Current smoking (%) 14 (40.0) 9 (22.0) 0.189
Coronary heart disease (%) 12 (34.3) 0 (0)  
Age (years) 43.7 ± 13.7 45.6 ± 12.7 0.802
Systolic blood pressure (mmHg) 129 ± 18 128 ± 16 0.607
Diastolic blood pressure (mmHg) 80 ± 11 81 ± 9 0.985
Body mass index (kg/m2) 26.2 (23.9 - 29.0) 23.7 (21.4 - 26.5) 0.001
Waist circumference (cm) 96.0 ± 10.8 84.7 ± 10.7 0.001
TC (mmol/l) 4.22 (3.69 - 5.17) 5.04 (4.31 - 5.60) 0.003
TG (mmol/l) 1.22 (1.02 - 1.62) 0.85 (0.72 - 1.08) < 0.0001
LDL-C (pmol/l) 2.68 (2.15 - 3.53) 2.79 (2.33 - 3.29) 0.316
HDL-C (pmol/l) 0.93 (0.81 - 0.99) 1.62 (1.35 - 1.91) < 0.0001
ApoA-I (mg/dl) 110 (104 - 117) 143 (129 - 159) < 0.0001
ApoA-II (mg/dl) 35 (29 - 40) 37 (32 - 40) 0.035
ApoB (mg/dl) 96 (83 - 111) 88 (78 - 106) 0.657
PON1 activity (nmol/min/ml) 155 (106-211) 133 (92-265) 0.614
hsCRP (mg/l) 1.03 (0.51 - 2.91) 0.46 (0.24 - 1.71) 0.007
  1. Data are expressed as means ± SD or median (lower and upper quartile). The two P values from the top are evaluated using χ2 tests. Other data are adjusted for age, sex, and smoking status.